California 2023-2024 Regular Session

California Senate Bill SB1502

Introduced

2/16/24

Introduced

2/16/24

Refer

2/29/24

Refer

3/20/24

Refer

3/20/24

Refer

4/3/24

Refer

4/3/24

Report Pass

4/11/24

Report Pass

4/11/24

Refer

4/15/24

Refer

4/15/24

Report Pass

5/16/24

Report Pass

5/16/24

Engrossed

5/22/24

Refer

6/3/24

Refer

6/3/24

Refer

6/6/24

Refer

6/6/24

Caption

Controlled substances: xylazine.

Latest CA SB1502 Activity

View All Events: CA 2023-2024 Regular Session SB1502

Companion Bills

No companion bills found.

Previously Filed As

CA SB6

Controlled substances: xylazine.

CA AB3029

Controlled substances.

CA A1526

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

CA S191

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

CA A5448

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

CA S3902

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

CA A5488

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances; requires reporting of xylazine prescriptions.

CA HB0077

CONTROLLED SUB-XYLAZINE

CA S4045

Requires controlled dangerous substances seized by law enforcement officers to be tested for presence of xylazine; requires reporting to DOH.

CA AB527

Controlled substances.

Similar Bills

CA SB6

Controlled substances: xylazine.

CA AB3029

Controlled substances.

CA AB1598

Controlled substances: paraphernalia: controlled substance testing.

CA AB2783

Controlled substances: hydrocodone combination products: schedules.

CA AB2136

Controlled substances: analyzing and testing.

CA AB2589

Controlled substances: human chorionic gonadotropin.